Colombo Cohort Captures Chikungunya Susceptibility Before the 2025 Outbreak
A community-based cohort in Colombo, Sri Lanka, offers a rare look at chikungunya seroprevalence immediately before the country’s large 2025 outbreak. By measuring age-stratified IgG patterns before epidemic spread accelerated, the study provides a snapshot of who was likely still immunologically exposed to infection and who may have remained vulnerable as transmission intensified.
The timing gives the work its clinical value. Pre-outbreak serology is difficult to obtain in real time, yet it is often the missing piece in arboviral epidemiology: without it, public health teams must infer susceptibility from old outbreaks, incomplete surveillance, or post hoc case counts. Here, the investigators used an existing longitudinal cohort in two Colombo communities to estimate baseline immunity before the epidemic changed the population profile. In practical terms, that matters for interpretation of what happened next, because outbreak size is shaped not only by vector density and viral introduction, but also by how many people were already primed by prior infection.
One sentence captures the main public health consequence: the city entered the 2025 outbreak with an uncertain but measurable burden of susceptibility.
Age-Stratified Serology and What It Can Reveal
The study’s design centered on age-stratified chikungunya seroprevalence, a sensible approach for a virus whose force of infection can differ sharply across generations. Older adults may have accumulated exposure during earlier circulation, while younger groups can remain immunologically naïve if transmission has been sporadic. Mapping IgG by age therefore helps separate historical exposure from current risk, especially when a community has lived through shifting mosquito ecology, housing patterns, and mobility trends.
The cohort included both urban and semi-urban communities with contrasting population density, housing characteristics, and socioeconomic conditions. That dual-community structure strengthens the epidemiologic picture because exposure to mosquito-borne infection rarely follows simple administrative boundaries. A household with standing water, crowding, different building materials, or limited vector control can experience very different transmission pressure than a nearby neighborhood with more favorable infrastructure. The study design was built to examine those differences rather than assume uniform risk across Colombo.
Household-level geospatial analysis added another layer. Chikungunya transmission is not only an individual event; it is shaped by where people sleep, how households cluster in space, and how microenvironments support mosquito breeding. By pairing geospatial assessment with multivariable models that accounted for household clustering and missing data, the investigators positioned the study to examine both personal and environmental determinants of seropositivity. That structure is especially useful in arboviral research, where infection often follows local pockets of vector exposure rather than broad citywide averages.
Why Household and Spatial Context Matter for Arboviral Risk
The biological logic behind the study is straightforward. Chikungunya virus is transmitted by mosquitoes, so human infection reflects more than host behavior alone; it also mirrors the built environment, the density of susceptible neighbors, and the persistence of breeding sites near homes. In dense urban settings, transmission can intensify when households are packed closely together and when water storage, waste, or drainage conditions favor vector proliferation. Semi-urban areas may carry a different balance of crowding and environmental exposure, which is why comparing both settings is so informative.
A serosurvey in this context functions as more than a retrospective measurement. It becomes a way to infer where the next epidemic may take hold fastest. If a community has relatively low seroprevalence, even modest viral introduction can produce steep case growth once mosquitoes are active and susceptible hosts are abundant. If prior exposure is widespread, case trajectories may be blunted or shifted toward younger, unexposed groups. The Colombo cohort was designed to estimate that baseline immunity before the 2025 outbreak removed the window for clean pre-epidemic measurement.
The Assay and Sampling Limits Shape Interpretation
The study’s limitations are clinically important and should be read alongside its strengths. Participants came from an existing longitudinal cohort rather than a population-based random sample, which limits generalisability beyond the two communities under study. It also constrains statistical power in some age groups. Those issues do not erase the value of the findings, but they do define the level at which the results can be applied: the data are strongest for the sampled communities and weakest when extrapolated to all of Colombo or to Sri Lanka more broadly.
The chikungunya-specific IgG assay was not independently validated in this population. In seroepidemiology, assay performance is not a technical footnote; it directly affects whether someone is classified as exposed or unexposed. If specificity or sensitivity shifts in the local setting, estimated seroprevalence can move with it. That uncertainty becomes especially relevant when the outcome is used to infer susceptibility before an outbreak. A small amount of misclassification can alter the apparent reservoir of immune versus susceptible people, particularly in age strata with fewer participants.
Residual confounding also remains possible. Socioeconomic and housing factors are tightly intertwined with mosquito exposure, but they are not always fully captured in models. Even when investigators adjust for several measured variables, unmeasured differences in water storage, household maintenance, travel patterns, or neighborhood-level vector control can still influence seropositivity. The study’s multivariable approach reduces but does not remove that concern.
Why This Study Still Matters Before the Epidemic Curve Moves
Despite those constraints, the study fills a rare epidemiologic gap. Pre-outbreak cohort data are difficult to assemble and even harder to interpret once transmission has surged. By anchoring serology to the period immediately before the 2025 outbreak, the investigators created a reference point for understanding how much of the population may have been vulnerable when the epidemic began. In arboviral outbreaks, that baseline is often what public health planners need most: a sense of where surveillance, vector control, and clinical preparedness should intensify first.
The comparison between urban and semi-urban communities also provides practical insight for local control efforts. If population density, housing structure, and socioeconomic context are associated with exposure, then prevention cannot rely on a single citywide message. Vector control, community education, and environmental interventions often need to be tailored to neighborhood conditions rather than delivered as a uniform package.
One clinical takeaway stands out: pre-outbreak immunity can be mapped, but it can also be misread if the assay and sampling frame are too narrow.
For clinicians and public health teams, the most useful next step is not speculation about the exact outbreak size. It is better surveillance, better assay validation, and broader population sampling in future seroepidemiologic work so that susceptibility estimates are not built on a small number of neighborhoods alone. The study establishes the value of looking before the epidemic arrives; its limitations show how carefully those measurements must be interpreted once the outbreak is already underway.